Anne Roelofs

Papers

Total Citations

H-Index

About

Anne Roelofs is a leading surgical outcomes researcher whose work has fundamentally reshaped the conversation around minimally invasive pancreatic surgery. Her primary research areas center on patient-reported outcomes, quality of life (QoL), and recovery metrics following complex abdominal procedures, with a specific focus on distal pancreatectomy. Roelofs made a landmark contribution as a key investigator in the LEOPARD randomized trial, which provided the highest level of evidence that minimally invasive distal pancreatectomy (MIDP) significantly shortens time to functional recovery and improves 30-day QoL compared to open surgery for nonmalignant disease. Her most-cited paper (2021, 35 citations) extends this work by rigorously evaluating long-term QoL and cosmetic satisfaction, demonstrating that the early benefits of MIDP are durable over time. This research has directly influenced clinical guidelines and patient counseling, shifting the paradigm toward minimally invasive approaches. By prioritizing the patient’s lived experience alongside traditional surgical metrics, Roelofs has established herself as a pivotal voice in evidence-based surgical innovation, bridging the gap between technical feasibility and meaningful patient-centered outcomes.